Tayade C

No ORCID on file · 42 papers in corpus · active 2012-2026

Study types

  • article 19
  • review 9
  • other 6
  • preprint 5

Condition tags

  • endometriosis 39
  • infertility 9
  • chronic_pelvic_pain 5
  • dysmenorrhea 2
  • dyspareunia 1
  • endometrioma 1
  • die_deep_infiltrating 1
  • adenomyosis 1
preprint 2026
·doi:10.64898/2026.06.11.731688

Abstract Endometriosis (EMS) is a chronic inflammatory disease characterized by ectopic endometrial-like tissue growth and immune dysregulation. Aberrant T cell responses are implicated in EMS pathogenesis, however, functional reprogramming…

article 2026
Cell death discovery ·doi:10.1038/s41420-026-03154-3

Correction to: Cell Death Discovery 10.1038/s41420-026-03015-z, published online 15 March 2026 In this article the author’s name ‘Neha Kamath’ has been published wrongly as ‘Kamath Neha’. The original article has been corrected.

review 2026
Frontiers in immunology ·doi:10.3389/fimmu.2026.1712360

Endometriosis is a chronic inflammatory, hormone dependent disorder that affects more than 200 million women worldwide. Immune dysfunction has emerged as one of the predominant mechanisms facilitating endometriosis lesion growth and surviva…

other 2026
Cell death discovery ·doi:10.1038/s41420-026-03015-z

Endometriosis is a chronic gynecological disorder marked by the growth of endometrial-like tissue outside the uterus, often leading to pelvic pain, inflammation, and infertility. Despite its global prevalence, diagnosis remains delayed, and…

2025
·doi:10.1101/2025.04.04.647212

Endometriosis is an inflammatory gynaecologic disease characterized by ectopic growth of endometrial-like tissue, resulting in pelvic pain and infertility. T-helper 9 (Th9) cells play a known role in various chronic inflammatory diseases. D…

preprint 2024
·doi:10.21203/rs.3.rs-3486655/v2

Abstract Endometriosis (EM), characterized by the presence of endometrial-like tissue outside the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive age. Despite its high prevalence, the molecula…

other 2024
F&S science ·doi:10.1016/j.xfss.2024.10.001

OBJECTIVE: To determine whether tertiary lymphoid structures (TLSs), which reflect organized immune cell aggregates present in non-lymphoid tissues, are consistent features of endometriosis lesions. DESIGN: Detailed histopathological analy…

preprint 2024
·doi:10.1101/2024.04.18.590132

Endometriosis is a chronic disorder in which endometrial-like tissue presents outside the uterus. Patients with endometriosis have been shown to exhibit aberrant immune responses within the lesion microenvironment and in circulation which c…

preprint 2023
·doi:10.1101/2023.10.11.561929

Abstract Endometriosis (EM), characterized by the presence of endometrial-like tissue outside the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive age. Despite its high prevalence, the molecular…

preprint 2023
·doi:10.1101/2023.12.07.570652

Abstract Endometriosis is a chronic inflammatory disease where endometrial-like tissue grows ectopically, resulting in pelvic pain and infertility. Interleukin (IL)-23 is established as a key contributor in the development and differentiati…

article 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1089098

Endometriosis is an estrogen dominant, chronic inflammatory disease characterized by the growth of endometrial-like tissue outside of the uterus. The most common symptoms experienced by patients include manifestations of chronic pelvic pain…

article 2022
Frontiers in immunology ·doi:10.3389/fimmu.2022.961599

Endometriosis is an estrogen dependent, chronic inflammatory disease characterized by the growth of endometrial lining outside of the uterus. Mast cells have emerged as key players in regulating not only allergic responses but also other me…

review 2022
Trends in molecular medicine ·doi:10.1016/j.molmed.2022.04.006

IL-33 is a member of the IL-1 family and was first identified as an alarmin that acts at mucosal barrier sites. However, IL-33 is now understood to be a pleiotropic cytokine that acts on a variety of immune and non-immune cell types to prom…

review 2022
Journal of cannabis research ·doi:10.1186/s42238-022-00163-8

Endometriosis patients experience debilitating chronic pain, and the first-line treatment is ineffective at managing symptoms. Although surgical removal of the lesions provides temporary relief, more than 50% of the patients experience dise…

article 2022
F&S science ·doi:10.1016/j.xfss.2022.04.007

OBJECTIVE: To identify immune cells, cytokines, and immune cell transcriptome in the menstrual effluent (ME) of women with endometriosis compared with that of healthy donors. DESIGN: Live immune cells were isolated from human ME samples an…

other 2021
JCI insight ·doi:10.1172/jci.insight.149699

Chronic inflammation and localized alterations in immune cell function are suspected to contribute to the progression of endometriosis and its associated symptoms. In particular, the alarmin IL-33 is elevated in the plasma, peritoneal fluid…

article 2021
F&S science ·doi:10.1016/j.xfss.2021.09.005

OBJECTIVE: To determine the involvement of the endocannabinoid (EC) family member in the pathophysiology of endometriosis (EMS). DESIGN: Mass spectrometry analysis of plasma and tissue samples from patients with EMS, controls, and a mouse …

article 2021
Frontiers in reproductive health ·doi:10.3389/frph.2021.726936

Endometriosis (EM) is characterized by the growth of endometrium-like tissue outside the uterus, leading to chronic inflammation and pelvic pain. Lesion proliferation, vascularization, and associated inflammation are the hallmark features o…

other 2020
Frontiers in immunology ·doi:10.3389/fimmu.2020.00108

Endometriosis is a debilitating gynecological disease characterized by the extrauterine presence of endometrial-like tissues located on the peritoneal membrane and organs of the pelvic cavity. Notably, dysfunctional immune activation in wom…

article 2019
JCI insight ·doi:10.1172/jci.insight.128846

With multifactorial etiologies, combined with disease heterogeneity and a lack of suitable diagnostic markers and therapy, endometriosis remains a major reproductive health challenge. Extracellular vesicles (EVs) have emerged as major contr…

article 2019
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.201902272r

Endometriosis is a chronic inflammatory, gynecological disease characterized by the presence of endometrial-like tissue lesions outside of the uterus. Neutrophils are elevated in the systemic circulation and peritoneal fluid of endometriosi…

review 2018
Trends in molecular medicine ·doi:10.1016/j.molmed.2018.07.004

Endometriosis is a chronic, inflammatory, estrogen-dependent disease characterized by the growth of endometrial tissue outside of the uterine cavity. Although the etiology of endometriosis remains elusive, immunological dysfunction has been…

article 2017
Scientific reports ·doi:10.1038/s41598-017-06081-7

Endometriosis, a major reproductive pathology affecting 8-10% of women is characterized by chronic inflammation and immune dysfunction. Human antigen R (HuR) and Tristetraprolin (TTP) are RNA binding proteins that competitively bind to cyto…

review 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.01.009

Endometriosis is a debilitating gynecologic disease affecting millions of women across the world, with symptoms including dysmenorrhea, chronic pelvic pain, and infertility. Theorized to stem from the phenomenon of retrograde menstruation, …

article 2017
Scientific reports ·doi:10.1038/s41598-017-18224-x

Endometriosis is a debilitating condition that is categorized by the abnormal growth of endometrial tissue outside the uterus. Although the pathogenesis of this disease remains unknown, it is well established that endometriosis patients exh…